Sex
Visit (Number) vs Cogscreen Pathfinder Number (PN) Thruput
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,105 | 71.9 | ± 18.0 | 71.5 | -9.0 | 133.0 | 411 | 1,516 |
CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 1,105 | 56.4 | ± 35.7 | 66.1 | -7.0 | 139.9 | 411 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 1,105 | 54.0 | ± 36.7 | 64.9 | -9.0 | 147.8 | 411 | 1,516 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 71.9 | ± 18.0 | 71.5 | -9.0 | 133.0 | 411 | 1,516 |
Male | 723 | 72.3 | ± 18.4 | 71.9 | -9.0 | 133.0 | 235 | 958 |
Female | 382 | 71.2 | ± 17.3 | 70.7 | -9.0 | 131.3 | 176 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 56.4 | ± 35.7 | 66.1 | -7.0 | 139.9 | 411 | 1,516 |
Male | 723 | 56.5 | ± 36.2 | 66.2 | -7.0 | 130.7 | 235 | 958 |
Female | 382 | 56.2 | ± 34.7 | 65.6 | -7.0 | 139.9 | 176 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Thruput
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 54.0 | ± 36.7 | 64.9 | -9.0 | 147.8 | 411 | 1,516 |
Male | 723 | 54.1 | ± 37.5 | 64.3 | -9.0 | 147.8 | 235 | 958 |
Female | 382 | 53.9 | ± 35.3 | 65.9 | -7.0 | 140.5 | 176 | 558 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 71.9 | ± 18.0 | 71.5 | -9.0 | 133.0 | 411 | 1,516 |
Native American | 18 | 70.6 | ± 20.8 | 67.5 | 20.9 | 102.6 | 10 | 28 |
Asian | 61 | 81.0 | ± 20.9 | 81.5 | 39.2 | 133.0 | 28 | 89 |
Black | 103 | 67.4 | ± 17.4 | 64.3 | 32.0 | 110.1 | 69 | 172 |
Hispanic | 77 | 75.1 | ± 18.2 | 71.5 | 33.8 | 114.3 | 39 | 116 |
White | 841 | 71.6 | ± 17.5 | 71.5 | -9.0 | 131.3 | 261 | 1,102 |
Other | 5 | 68.3 | ± 21.3 | 61.2 | 41.9 | 96.0 | 4 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 56.4 | ± 35.7 | 66.1 | -7.0 | 139.9 | 411 | 1,516 |
Native American | 18 | 41.4 | ± 36.3 | 55.2 | -6.0 | 83.8 | 10 | 28 |
Asian | 61 | 62.1 | ± 40.9 | 68.6 | -7.0 | 125.0 | 28 | 89 |
Black | 103 | 50.5 | ± 36.3 | 58.5 | -7.0 | 109.7 | 69 | 172 |
Hispanic | 77 | 61.2 | ± 34.8 | 66.7 | -7.0 | 130.7 | 39 | 116 |
White | 841 | 56.7 | ± 35.2 | 66.4 | -7.0 | 139.9 | 261 | 1,102 |
Other | 5 | 37.0 | ± 39.8 | 58.1 | -6.0 | 76.7 | 4 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Thruput
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 54.0 | ± 36.7 | 64.9 | -9.0 | 147.8 | 411 | 1,516 |
Native American | 18 | 47.3 | ± 36.6 | 63.5 | -6.0 | 84.2 | 10 | 28 |
Asian | 61 | 67.4 | ± 40.2 | 72.1 | -7.0 | 147.8 | 28 | 89 |
Black | 103 | 48.5 | ± 36.7 | 60.7 | -7.0 | 117.4 | 69 | 172 |
Hispanic | 77 | 57.7 | ± 36.8 | 68.9 | -7.0 | 116.5 | 39 | 116 |
White | 841 | 53.7 | ± 36.3 | 64.5 | -9.0 | 140.5 | 261 | 1,102 |
Other | 5 | 31.5 | ± 34.7 | 47.3 | -6.0 | 61.5 | 4 | 9 |